Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial.

Spirito, Alessandro; Kastrati, Adnan; Cao, Davide; Baber, Usman; Sartori, Samantha; Angiolillo, Dominick J; Briguori, Carlo; Cohen, David J; Dangas, George; Dudek, Dariusz; +16 more... Escaned, Javier; Gibson, C Michael; Zhang, Zhongjie; Huber, Kurt; Kaul, Upendra; Kornowski, Ran; Kunadian, Vijay; Han, Ya-Ling; Mehta, Shamir R; Sardella, Gennaro; Sharma, Samin; Shlofmitz, Richard A; Vogel, Birgit; Collier, Timothy; Pocock, Stuart; Mehran, Roxana; (2023) Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial. European Heart Journal - Cardiovascular Pharmacotherapy, 9 (4). pp. 328-336. ISSN 2055-6837 DOI: https://doi.org/10.1093/ehjcvp/pvad006

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/ehjcvp/pvad006

Abstract

Share

Download

Filename: Spirito_etal_2023_Ticagrelor-with-or-without-aspirin.pdf

Description: This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar